Abpro Holdings (ABPO) Cash & Equivalents (2022 - 2026)
Abpro Holdings (ABPO) recorded Cash & Equivalents of $4.24 million in Q2 2026, up 110.3% from $2.01 million a year earlier but down 21.5% from the prior quarter.
Powered by 
Analysis
Abpro Holdings (ABPO) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Abpro Holdings reported Cash & Equivalents of $67,000, down 97.8% from FY2024.
- Annual Cash & Equivalents has a three-year compound annual growth rate of -44.5% (FY2022 to FY2025).
- Across earlier years, Cash & Equivalents came in at $2.99 million in FY2024 (+247.5%), $861,000 in FY2023 (+119.4%) and $392,446 in FY2022.
- Quarterly Cash & Equivalents has ranged from $67,000 in Q4 2025 to $5.4 million in Q1 2026 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in six of the last eight quarters, with growth averaging 252.1%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 897.0% in Q2 2025, against a decline of 97.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.4 million (Q1 2026), $67,000 (Q4 2025) and $343,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Abpro Holdings | 2.06 Mn | 2.61 Mn | - | 4.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.24 Mn |
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 202,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 861,000.00 |
| Sep 30, 2023 | 948,153.00 |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 295,224.00 |
| Dec 31, 2022 | 392,446.00 |
| Sep 30, 2022 | 189,031.00 |
| Jun 30, 2022 | 295,028.00 |
| Mar 31, 2022 | 330,569.00 |
API Access
Abpro Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABPO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABPO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABPO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();